Median Diagnostics Inc. (XKON:233250)
South Korea flag South Korea · Delayed Price · Currency is KRW
14,500
+500 (3.57%)
Last updated: May 12, 2025

Median Diagnostics Statistics

Total Valuation

XKON:233250 has a market cap or net worth of KRW 25.29 billion.

Market Cap 25.29B
Enterprise Value n/a

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

XKON:233250 has 1.75 million shares outstanding.

Current Share Class 1.75M
Shares Outstanding 1.75M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 1.18%
Owned by Institutions (%) n/a
Float 259,012

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 3.22
PB Ratio 4.11
P/TBV Ratio 4.39
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.31, with a Debt / Equity ratio of 0.70.

Current Ratio 4.31
Quick Ratio 3.20
Debt / Equity 0.70
Debt / EBITDA 2.72
Debt / FCF -3.07
Interest Coverage 2.99

Financial Efficiency

Return on equity (ROE) is -8.16% and return on invested capital (ROIC) is 6.02%.

Return on Equity (ROE) -8.16%
Return on Assets (ROA) 4.70%
Return on Invested Capital (ROIC) 6.02%
Return on Capital Employed (ROCE) 8.62%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.51
Inventory Turnover 2.63

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +31.82% in the last 52 weeks. The beta is 0.26, so XKON:233250's price volatility has been lower than the market average.

Beta (5Y) 0.26
52-Week Price Change +31.82%
50-Day Moving Average 15,365.80
200-Day Moving Average 13,958.50
Relative Strength Index (RSI) 45.27
Average Volume (20 Days) 20

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, XKON:233250 had revenue of KRW 7.86 billion and -567.58 million in losses. Loss per share was -496.00.

Revenue 7.86B
Gross Profit 4.95B
Operating Income 1.17B
Pretax Income -1.17B
Net Income -567.58M
EBITDA 1.59B
EBIT 1.17B
Loss Per Share -496.00
Full Income Statement

Balance Sheet

The company has 3.66 billion in cash and 4.33 billion in debt, giving a net cash position of -672.04 million or -384.79 per share.

Cash & Cash Equivalents 3.66B
Total Debt 4.33B
Net Cash -672.04M
Net Cash Per Share -384.79
Equity (Book Value) 6.15B
Book Value Per Share 5,378.46
Working Capital 5.11B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.05 million and capital expenditures -1.41 billion, giving a free cash flow of -1.41 billion.

Operating Cash Flow -6.05M
Capital Expenditures -1.41B
Free Cash Flow -1.41B
FCF Per Share -809.17
Full Cash Flow Statement

Margins

Gross margin is 63.01%, with operating and profit margins of 14.86% and -7.22%.

Gross Margin 63.01%
Operating Margin 14.86%
Pretax Margin -14.93%
Profit Margin -7.22%
EBITDA Margin 20.25%
EBIT Margin 14.86%
FCF Margin n/a

Dividends & Yields

XKON:233250 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -2.24%
FCF Yield -5.59%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

XKON:233250 has an Altman Z-Score of 1.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.71
Piotroski F-Score n/a